chr14-50118582-G-C
Variant summary
Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006939.4(SOS2):c.3761C>G(p.Thr1254Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000112 in 1,613,994 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1254M) has been classified as Likely benign.
Frequency
Consequence
NM_006939.4 missense
Scores
Clinical Significance
Conservation
Publications
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 9Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, G2P
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -6 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_006939.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SOS2 | NM_006939.4 | MANE Select | c.3761C>G | p.Thr1254Arg | missense | Exon 23 of 23 | NP_008870.2 | ||
| SOS2 | NM_001411020.1 | c.3662C>G | p.Thr1221Arg | missense | Exon 22 of 22 | NP_001397949.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SOS2 | ENST00000216373.10 | TSL:1 MANE Select | c.3761C>G | p.Thr1254Arg | missense | Exon 23 of 23 | ENSP00000216373.5 | ||
| SOS2 | ENST00000543680.5 | TSL:1 | c.3662C>G | p.Thr1221Arg | missense | Exon 22 of 22 | ENSP00000445328.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 31 show subpopulations
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461870Hom.: 0 Cov.: 33 AF XY: 0.0000151 AC XY: 11AN XY: 727242 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152124Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 74308 show subpopulations
ClinVar
Submissions by phenotype
Noonan syndrome 9 Uncertain:2
This sequence change replaces threonine, which is neutral and polar, with arginine, which is basic and polar, at codon 1254 of the SOS2 protein (p.Thr1254Arg). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SOS2-related conditions. ClinVar contains an entry for this variant (Variation ID: 542403). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt SOS2 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
The SOS2 c.3761C>G (p.Thr1254Arg) missense variant results in the substitution of threonine at amino acid position 1254 with arginine. To our knowledge, this variant has not been reported in the peer-reviewed literature. This variant is reported in the Genome Aggregation Database in one allele at a frequency of 0.000015 in the European (non-Finnish) population (version 3.1.2). Almost all known pathogenic variants in the SOS2 gene reported to-date in the literature are missense variants located in a hotspot region in the N-terminus of the protein within the Dbl-homology domain between amino acids 198-388, whereas this variant is located close to the C-terminus of the protein where no pathogenic variants have been reported so far (PMID: 26173643; PMID: 32788663; PMID: 34205562). Additionally, the known pathogenic variants in this gene have either been inherited from an affected parent or occurred de novo. Based on the available evidence, the c.3761C>G (p.Thr1254Arg) variant is classified as a variant of uncertain significance for Noonan syndrome.
Cardiovascular phenotype Uncertain:1
The c.3761C>G (p.T1254R) alteration is located in exon 23 (coding exon 23) of the SOS2 gene. This alteration results from a C to G substitution at nucleotide position 3761, causing the threonine (T) at amino acid position 1254 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at